Molecular chaperones: Toward new therapeutic tools

Biomedicine and Pharmacotherapy

Volumn 65, Issue 4, 2011, Pages 239-243

  Almeida, Mauro B ^a   Do Nascimento, José Luiz Martins ^a   Herculano, Anderson Manoel ^a   Crespo López, Maria Elena ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

Cancer; Chaperones; Neurodegenerative disease; Neuroprotection

Indexed keywords

17 ALLYLAMINO DEMETHOXY GELDANAMYCIN; ANTINEOPLASTIC AGENT; CATHEPSIN; CHAPERONE; CISPLATIN; DOXORUBICIN; GELDANAMYCIN; HEAT SHOCK PROTEIN 100; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MET TYROSINE KINASE; METALLOPROTEIN; NITRIC OXIDE SYNTHASE; PACLITAXEL; PROTEASOME INHIBITOR; PROTEIN KINASE; PROTEIN MSH2; PROTEIN P53; PROTEIN TYROSINE KINASE; PURINE SCAFFOLD INHIBITOR; RADICICOL; SMALL HEAT SHOCK PROTEIN; TIN CHLORIDE; TRICHOSTATIN A; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN;

ALZHEIMER DISEASE; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER PATIENT; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL MEMBRANE; CELL MEMBRANE FLUIDITY; CELL PROTECTION; CELL STRUCTURE; CELL SURVIVAL; CHRONIC INFLAMMATION; DEGENERATIVE DISEASE; DIABETES MELLITUS; DRUG BINDING; DRUG TARGETING; ELECTRONEUROLOGY; ENZYME INHIBITION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUNTINGTON CHOREA; HYPERLIPIDEMIA; IMMUNE DEFICIENCY; IMMUNOMODULATION; INFECTION; INJURY; LOW DRUG DOSE; LUNG SMALL CELL CANCER; LYMPHOMA; MELANOMA; METASTASIS; NEOPLASM; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REVIEW; STIMULUS; STROKE; TUMOR CELL; TUMOR ESCAPE; TUMOR GROWTH; UPREGULATION;

ANIMALS; HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR CHAPERONES; NEOPLASMS; NEURODEGENERATIVE DISEASES; PROTEIN FOLDING;

EID: 79960430517     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.04.025     Document Type: Review

References (55)

1. Sharp P.S., et al. Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression. Neurobiol Dis 2008, 30(1):42-55.
2. Klass M.G., et al. Heat shock proteins, endothelin, and peripheral neuronal injury. Neurosci Lett 2008, 433(3):188-193.
3. Tantucci M., et al. Induction of heat shock protein 70 reduces the alteration of striatal electrical activity caused by mitochondrial impairment. Neuroscience 2009, 163(3):735-740.
4. Sittler A., et al. Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease. Hum Mol Genet 2001, 10(12):1307-1315.
5. Soti C., et al. Heat shock proteins as emerging therapeutic targets. Br J Pharmacol 2005, 146(6):769-780.
6. Yang I., Fang S., Parsa A.T. Heat shock proteins in glioblastomas. Neurosurg Clin N Am 2010, 21(1):111-123.
7. Ciocca D.R., Calderwood S.K. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005, 10(2):86-103.
8. Zhan X., et al. Recombinant Fv-Hsp70 protein mediates neuroprotection after focal cerebral ischemia in rats. Stroke 2010, 41(3):538-543.
9. Powers M.V., et al. Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone?. Cell Cycle 2010, 9(8):1542-1550.
10. Lindquist S., Craig E.A. The heat-shock proteins. Annu Rev Genet 1988, 22:631-677.
11. Laudanski K., Wyczechowska D. The distinctive role of small heat shock proteins in oncogenesis. Arch Immunol Ther Exp (Warsz) 2006, 54(2):103-111.
12. Wegele H., Muller L., Buchner J. Hsp70 and Hsp90 - a relay team for protein folding. Rev Physiol Biochem Pharmacol 2004, 151:1-44.
13. Calderwood S.K., et al. Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 2006, 31(3):164-172.
14. Spiess C., et al. Mechanism of the eukaryotic chaperonin: protein folding in the chamber of secrets. Trends Cell Biol 2004, 14(11):598-604.
15. Bigotti M.G., Clarke A.R. Chaperonins: the hunt for the Group II mechanism. Arch Biochem Biophys 2008, 474(2):331-339.
16. Arrigo A.P. [Heat shock proteins as molecular chaperones]. Med Sci (Paris) 2005, 21(6-7):619-625.
17. Pratt W.B., Toft D.O. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 2003, 228(2):111-133.
18. Soti C., Csermely P. Aging and molecular chaperones. Exp Gerontol 2003, 38(10):1037-1040.
19. Hooper P.L. Hot-tub therapy for type 2 diabetes mellitus. N Engl J Med 1999, 341(12):924-925.
20. Landriscina M., et al. Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. Gynecol Oncol 2010, 117(2):177-182.
21. Shigapova N., et al. Membrane fluidization triggers membrane remodeling which affects the thermotolerance in Escherichia coli. Biochem Biophys Res Commun 2005, 328(4):1216-1223.
22. Ferdinandy P., Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 2003, 138(4):532-543.
23. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100(1):57-70.
24. Huang C., et al. Multi-chaperone-peptide-rich mixture from colo-carcinoma cells elicits potent anticancer immunity. Cancer Epidemiol 2010.
25. Ekman S., et al. Hsp90 as a therapeutic target in patients with oesophageal carcinoma. Expert Opin Ther Targets 2010, 14(3):317-328.
26. Altieri D.C. Mitochondrial Hsp90 chaperones as novel molecular targets in prostate cancer. Future Oncol 2010, 6(4):487-489.
27. Shiota M., et al. Heat shock cognate protein 70 is essential for Akt signaling in endothelial function. Arterioscler Thromb Vasc Biol 2010, 30(3):491-497.
28. Karapanagiotou E.M., Syrigos K., Saif M.W. Heat shock protein inhibitors and vaccines as new agents in cancer treatment. Expert Opin Investig Drugs 2009, 18(2):161-174.
29. Tsutsumi S., Neckers L. Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis. Cancer Sci 2007, 98(10):1536-1539.
30. Binder R.J., Vatner R., Srivastava P. The heat-shock protein receptors: some answers and more questions. Tissue Antigens 2004, 64(4):442-451.
31. Eustace B.K., et al. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat Cell Biol 2004, 6(6):507-514.
32. Tsutsumi S., et al. A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene 2008, 27(17):2478-2487.
33. Kamal A., et al. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 2003, 425(6956):407-410.
34. Vasilevskaya I.A., Rakitina T.V., O'Dwyer P.J. Geldanamycin and its 17-allylamino-17-demethoxy analogue antagonize the action of cisplatin in human colon adenocarcinoma cells: differential caspase activation as a basis for interaction. Cancer Res 2003, 63(12):3241-3246.
35. Vigh L., et al. Bimoclomol: a non-toxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects. Nat Med 1997, 3(10):1150-1154.
36. Katsuno M., et al. Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proc Natl Acad Sci U S A 2005, 102(46):16801-16806.
37. Waza M., et al. Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein. J Mol Med 2006, 84(8):635-646.
38. Dickey C.A., et al. Brain CHIP: removing the culprits in neurodegenerative disease. Trends Mol Med 2007, 13(1):32-38.
39. Kalmar B., et al. The effect of treatment with BRX-220, a co-inducer of heat shock proteins, on sensory fibers of the rat following peripheral nerve injury. Exp Neurol 2003, 184(2):636-647.
40. Stetler R.A., et al. Hsp27 protects against ischemic brain injury via attenuation of a novel stress-response cascade upstream of mitochondrial cell death signaling. J Neurosci 2008, 28(49):13038-13055.
41. Calabrese V., et al. Redox regulation of heat shock protein expression by signaling involving nitric oxide and carbon monoxide: relevance to brain aging, neurodegenerative disorders, and longevity. Antioxid Redox Signal 2006, 8(3-4):444-477.
42. Gifondorwa D.J., et al. Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J Neurosci 2007, 27(48):13173-13180.
43. Kieran D., et al. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat Med 2004, 10(4):402-405.
44. Griffin T.M., Valdez T.V., Mestril R. Radicicol activates heat shock protein expression and cardioprotection in neonatal rat cardiomyocytes. Am J Physiol Heart Circ Physiol 2004, 287(3):H1081-H1088.
45. Kupatt C., et al. Heat shock protein 90 transfection reduces ischemia-reperfusion-induced myocardial dysfunction via reciprocal endothelial NO synthase serine 1177 phosphorylation and threonine 495 dephosphorylation. Arterioscler Thromb Vasc Biol 2004, 24(8):1435-1441.
46. Chung E., Leinwand L.A. Rescuing cardiac malfunction: the roles of the chaperone-like small heat shock proteins. Circ Res 2008, 103(12):1351-1353.
47. Bielecka-Dabrowa A., et al. HSP 70 and atherosclerosis - protector or activator?. Expert Opin Ther Targets 2009, 13(3):307-317.
48. Perdrizet G.A., et al. Heat shock and recovery protects renal allografts from warm ischemic injury and enhances HSP72 production. Transplant Proc 1993, 25(1 Pt 2):1670-1673.
49. Fischer B., et al. Immunomodulation with heat shock protein DiaPep277 to preserve beta cell function in type 1 diabetes - an update. Expert Opin Biol Ther 2010, 10(2):265-272.
50. Hauet-Broere F., et al. Heat shock proteins induce T cell regulation of chronic inflammation. Ann Rheum Dis 2006, 65(Suppl.3):piii65-piii68.
51. Federico A., et al. Heat shock protein 27 expression in patients with chronic liver damage. Immunobiology 2005, 209(10):729-735.
52. Stetler R.A., et al. Heat shock proteins: cellular and molecular mechanisms in the central nervous system. Prog Neurobiol 2010, 92(2):184-211.
53. Truettner J.S., et al. Subcellular stress response and induction of molecular chaperones and folding proteins after transient global ischemia in rats. Brain Res 2009, 1249:9-18.
54. Daugaard M., et al. Lens epithelium-derived growth factor is an Hsp70-2 regulated guardian of lysosomal stability in human cancer. Cancer Res 2007, 67(6):2559-2567.
55. Pearl L.H., Prodromou C. Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu Rev Biochem 2006, 75:271-294.